Trials / Completed
CompletedNCT01739244
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Sylentis, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this dose-finding clinical trial is to evaluate the systemic tolerability, local tolerability and intraocular pressure lowering effect of three different doses of SYL040012 in subjects with ocular hypertension or open-angle glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYL040012 | Ocular topical administration of SYL040012 for 14 consecutive days |
| DRUG | Placebo | Ocular topical administration of placebo for 14 consecutive days |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-12-03
- Last updated
- 2013-06-10
Locations
11 sites across 3 countries: Estonia, Germany, Spain
Source: ClinicalTrials.gov record NCT01739244. Inclusion in this directory is not an endorsement.